NEW YORK (GenomeWeb News) – Flow cytometry systems maker Accuri Cytometers has received $4 million in Series D financing from current and new investors, the company said today.

The Ann Arbor, Mich.-based firm said it plans to use the funds support manufacturing and marketing of its C6 Flow Cytometer and the CSampler, which is used to automate the C6.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.